文献速递介入腹部DSACTMRPET

肝细胞癌的放射性栓塞治疗:基础入门

Radioembolisation of hepatocellular carcinoma: a primer.
PubMed 文献 · Clin Radiol · 2017-10-09

经动脉放射性栓塞(TARE)作为肝细胞癌及结直肠肝转移的局部区域治疗选择日益被接受,通过选择性注入放射性微球(通常为钇-90)实现肿瘤内放射治疗。由于放射性栓塞与微栓塞的联合效应,其随访影像表现与其他经动脉治疗显著不同。本文综述钇-90放射性栓塞的患者选择、治疗计划、辐射剂量学与治疗、副作用、随访影像及未来方向。

要点

  • TARE是经导管选择性内放射治疗,通常使用钇-90微球。
  • 因放射性加微栓塞双重效应,随访影像表现不同于其他经动脉治疗。
  • 放射科医生需熟悉TARE以参与多学科会议讨论并指导后续管理。

核心结论

  • TARE作为肝细胞癌及结直肠肝转移的局部区域治疗选择日益被接受,放射科医生应熟悉其各方面以促进多学科讨论。

研究设计与样本

  • 综述,涵盖钇-90放射性栓塞的患者选择、治疗计划、辐射剂量学与治疗、副作用、随访影像及未来方向。

关键影像表现/征象

  • 由于放射性栓塞与微栓塞的联合效应,随访影像表现与其他经动脉治疗显著不同。

临床应用与阅片要点

  • 放射科医生应熟悉TARE,以便在多学科会议上进行适当讨论并指导进一步管理。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Transarterial radioembolisation (TARE) has gained increasing acceptance as an additional/alternative locoregional treatment option for hepatocellular carcinoma, and colorectal hepatic metastases that present beyond potentially curative options. This is a catheter-based transarterial selective internal brachytherapy that involves injection of radioactive microspheres (usually Y-90) that are delivered selectively to the liver tumours. Owing to the combined radioactive and microembolic effect, the findings at follow-up imaging are significantly different from that seen with other transarterial treatment options. Considering increasing confidence among clinicians, refinement in techniques and increasing number of ongoing trials, TARE is expected to gain further acceptance and become an important tool in the armamentarium for the treatment of liver malignancies. So it is imperative that all radiologists involved in the management of liver malignancies are well versed with TARE to facilitate appropriate discussion at multidisciplinary meetings to direct further management. In this article, we provide a comprehensive review on various aspects of radioembolisation with Y-90 for hepatocellular carcinoma including the patient selection, treatment planning, radiation dosimetry and treatment, side effects, follow-up imaging and future direction.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Venkatanarasimha N, Gogna A, Tong KTA, et al. Radioembolisation of hepatocellular carcinoma: a primer. Clin Radiol. 2017. PMID: 29032802. doi:10.1016/j.crad.2017.07.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。